SeaStar Medical Announces 2026 Milestones
Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical’s first-in-class SCD...
Clinical Trial
Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
Vaxxas HD-MAP Self Administration Vaxxas HD-MAP Self Administration Vaxxas CEO David Peacock Vaxxas CEO David Peacock Vaxxas HD-MAP Vaxxas HD-MAP...
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
– Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription...
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
David Zaccardelli, Pharm.D. joins Board as Chair Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026...
4DMT Provides Company Update and Anticipated Development Milestones for 2026
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in...
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
COPENHAGEN, Denmark, January 7, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered...
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
The listing on one of the world’s largest global cryptocurrency exchanges expands market access and secondary liquidity for Enlivex’s primary...
Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards
MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today...
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang,...
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026
COVINGTON, Ky., Jan. 6, 2026 /PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic...
WELT Unveils the World’s First “AI-Combo Drug” at CES 2026
Turning Any Medication into a Precision AI-Combo Drug through Simple QR-Code Integration LAS VEGAS, NV / ACCESS Newswire / January...
New Study Finds Millions of Americans With Heart Failure Are Not Receiving Proven, Life-Saving Therapy
Nationwide analysis from Motive Medical Intelligence reveals widespread underuse of low-cost, evidence-based medications proven to decrease the risk of deathSAN...
St. Baldrick’s Foundation Announces 2026 Ambassadors
Los Angeles, California--(Newsfile Corp. - January 6, 2026) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
How Does Community-Based Research Deliver Faster Results and Greater Access? Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insights into community-based research models and how they compare to traditional site-based models. Attendees will...
WCG Unveils 2026 Trends and Insights Report: Charting a New Era of Readiness, Innovation, and Human-Centric Clinical Research
CARY, N.C., Jan. 6, 2026 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio
FORT WORTH, Texas, Jan. 6, 2026 /PRNewswire/ -- NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of John...
Behind the Relapse No One Saw Coming: How First Ascent Biomedical Is Changing Cancer Treatment Decisions
Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine...
Article About Groundbreaking Results from Study of Jaguar Health’s Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
Article discusses results demonstrating parenteral support (PS) reduction ranging from 12 to 37% in ongoing proof-of-concept study of crofelemer in...
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
NAPLES, FL / ACCESS Newswire / January 6, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell...
Mmimetika Appoints Metabolic Health Expert Karan Sarin as CEO to Lead Global Commercialization
AARHUS | Author of "Sick Nation" and veteran startup operator joins as company advances lactate-ketone ester through regulatory approval with...